In the first study, the authors did not find any significant difference in biochemical hyperandrogenism in both intra and inter-groups, despite the significant improvement in anthropometric parameters in the group treated with liraglutide [57]
PCOS ( now known as Polyendocrine Metabolic Ovarian Syndrome) Depression, anxiety, or high stress
Randomized controlled trials have shown: Improved Ovulatory Function: Liraglutide and exenatide therapy restore menstrual cyclicity and spontaneous ovulation in women with obesity-associated PCOS
Its not a household name yet, and for good reasonits firmly in the investigational stage
Injection site reactions are the most common complaint
But personalized obesity care in the future might As doctors learn why GLP-1s don't work for about 50% of people, they are also learning more about the complex drivers of obesity